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Malignant lymphomas that develop in the orbit and ocu-
lar adnexa account for 8% of all extranodal lymphomas 
[1,2]. Most ocular and orbital lymphomas are non-Hodg-
kin’s B-cell lymphoma [1]. At these sites, with the excep-
tion of B-cell lymphoma, lymphoblastic diseases are rare 
and occur in only 1% to 3% of cases [2]. Ocular and ocular 
adnexa T-cell lymphomas are rare. There are few cases of 
nasal natural killer T-cell lymphoma (NKTL) reported in 
the medical literature [1-4]. Additionally, pathologically 
confirmed intraocular involvement of nasal NKTL, such 
as the case reported here, is very rare [3]. 
Case Report
A 57-year-old woman presented with a three-day his-
tory of photophobia and diplopia in the left eye. She was 
diagnosed with histologically confirmed nasal NKTL of 
the right nasal cavity one month prior. The Snellen visual 
acuity of the affected eye with correction was 1.0 / 0.63, 
and the intraocular pressure in the right and left eyes was 
17 and 18 mmHg, respectively. The patient had mild left 
eye conjunctival injection, ptosis, and swelling of the eye-
lid. The left pupil was fully dilated with no pupillary light 
reflex. Ocular movement on left-upper gaze was limited in 
the left eye. Five days later, the left corrected visual acuity 
deteriorated and ptosis worsened. Slit lamp examination 
revealed anterior uveitis refractory to topical steroid treat-
ment. Opthalmoplegia, vitreous opacity, and an iris mass 
developed in the left eye (Fig. 1A and 1B). Orbital magnet-
ic resonance imaging and cerebrospinal fluid investigations 
were unremarkable. Aqueous humor aspiration from the 
anterior chamber was performed with a 26-gauge needle. 
Thirty-five percent of the cells obtained from the aspira-
tion were morphologically atypical lymphocytes. 
The patient was diagnosed with intraocular dissemina-
tion of the lymphoma. Treatment with intravitreal triam-
cinolone injections, radiotherapy, and chemotherapy was 
administered. Skin manifestations of the lymphoma were 
noted 40 days post-chemotherapy (Fig. 2A). Skin biopsy 
confirmed neoplastic infiltration of small- to medium-
sized pleomorphic lymphocytes with irregular nuclei, 
inconspicuous nucleoli, and scant cytoplasm (Fig. 2B). Im-
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Herein, we report a case of nasal natural killer T-cell lymphoma (NKTL) with intraocular involvement. A 57-year-
old woman was referred due to a three-day history of photophobia and diplopia in the left eye. One-month 
previously, she was diagnosed with nasal NKTL of the right nasal cavity. Ophthalmic examination revealed 
conjunctival injection and ptosis. The left pupil was fully dilated and non-reactive to light. Ocular motion was 
restricted on left-upper gaze. Five days later, anterior uveitis developed and persisted despite topical steroid 
treatment. An orbital magnetic resonance imaging was without specific findings, however, ophthalmoplegia, 
vitreous opacity, and an iris mass were observed. A diagnostic anterior chamber aspiration was performed. 
Aqueous humor aspiration revealed 35% morphologically atypical lymphocytes. After an intravitreal 
triamcinolone injection, radiotherapy and chemotherapy were administered; this resolved the uveitis and iris 
mass. When refractory uveitis or orbital pseudotumor occurs in patients with nasal NKTL, ocular and orbital 
involvement of the NKTL should be considered. 
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82-51-990-3026, E-mail: hiatus@ns.kosinmed.co.krmunohistochemical staining was positive for CD56 (Fig. 
2C) and CD3 (Fig. 2D). The patient was diagnosed with 
nasal NKTL with ocular involvement. After receiving ra-
diotherapy at 900 cGy, her visual acuity improved and her 
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Fig. 1. (A) Fundoscopy revealed vitreous haziness and opacity. (B) Slit lamp exam revealed a nodular, depigmented, mass-like appear-
ance of the iris (black arrow) and a pinkish lump in the iris (white arrow).
A
Fig. 2. (A) This photograph 
demonstrates multiple ery-
thematous and violaceous, well-
defined, coin-sized plaques and 
nodules in the lower limbs. (B) 
The neoplastic infiltrate was 
composed of small- to medium-
sized pleomorphic lymphocytes 
with irregular nuclei, incon-
spicuous nucleoli, and scant cy-
toplasm. (C) Immunotype was 
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anterior uveitis, vitreous opacity, and iris mass resolved 
(Fig. 3A and 3B). However, the patient’s condition contin-
ued to deteriorate despite radiotherapy and chemotherapy, 
and her ptosis and ophthalmoplegia gradually progressed. 
She died of sepsis three months after diagnosis. 
Discussion
Extranodal NKTL, including nasal NKTL, previously 
known as lethal midline granuloma, is a definitive diag-
nostic entity according to the World Health Organization 
lymphoma classification [1,4,5]. The nasal cavity is the 
most common site of involvement. However, histopatho-
logically identical tumors may be identified at other ex-
tranodal sites, including the skin, muscle, gastrointestinal 
tract, liver, kidney, and retroperitoneal space [6,7]. Orbital 
and adnexal involvement has been infrequently reported 
in patients with this disorder [6]. There are few reported 
cases of nasal NKTL involving the orbit and/or ocular ad-
nexa [2,6]. Coupland et al. [2] and Woog et al. [6] reported 
the formation of chronic uveitis and vitritis as intraocular 
manifestations of NKTL. Cimino et al. [3] did report a case 
of histologically confirmed nasal NKTL with intraocular 
involvement, however, in most cases intraocular involve-
ment has not been confirmed histologically. The presence 
of intraocular involvement raises the possibility of lepto-
meningeal or central nervous system dissemination, and 
prompts consideration for external-beam radiotherapy to 
the eye and orbit in addition to systemic chemotherapy 
[1,6,8]. NKTL involving the ocular adnexa is generally a 
rapidly progressing disease, with a short survival from 
time of diagnosis, despite standard therapy [6,9,10]. This 
was true in the current case as well; the patient died three 
months after diagnosis. Since NKTL with ocular and or-
bital involvement is very rare and is characterized by rapid 
disease progression and a poor prognosis, NKTL should be 
considered in the differential diagnosis of uveitis or orbital 
pseudotumor refractory to therapy. 
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